Literature DB >> 3099910

Primary pulmonary hypertension.

T Higenbottam.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3099910      PMCID: PMC1342234          DOI: 10.1136/bmj.293.6560.1456

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  24 in total

Review 1.  [Primary pulmonary hypertension].

Authors:  F Loogen; A Both
Journal:  Z Kardiol       Date:  1976-01

2.  Idiopathic pulmonary hypertension.

Authors:  J W BROWN; D HEATH; W WHITAKER
Journal:  Br Heart J       Date:  1957-01

3.  [Are the primary vascular forms of chronic pulmonary heart disease becoming more common?].

Authors:  H P Gurtner; M Gertsch; C Salzmann; M Scherrer; P Stucki; F Wyss
Journal:  Schweiz Med Wochenschr       Date:  1968-10-12

4.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

5.  Surgical management of chronic pulmonary embolism: surgical treatment and late results.

Authors:  P O Daily; G G Johnston; C J Simmons; K M Moser
Journal:  J Thorac Cardiovasc Surg       Date:  1980-04       Impact factor: 5.209

6.  Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound.

Authors:  L Hatle; B A Angelsen; A Tromsdal
Journal:  Br Heart J       Date:  1981-02

7.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  J M Rubino; J S Schroeder
Journal:  Br Heart J       Date:  1979-09

8.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

9.  Oral hydralazine therapy for primary pulmonary hypertension.

Authors:  L J Rubin; R H Peter
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

10.  Regression of primary pulmonary hypertension.

Authors:  P D Bourdillon; C M Oakley
Journal:  Br Heart J       Date:  1976-03
View more
  1 in total

1.  Time course of the effects of epoprostenol on effective pulmonary blood flow in normal volunteers.

Authors:  A Bush; C M Busst; A Millar; N Syrett
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.